Endometrial Cancer Market Provides an In-Depth Insight of Growth Factors and Upcoming Trends, Opportunities by Types and Application to 2026
Global Endometrial Cancer is Estimated to Grow Exponentially at a
Significant CAGR over the Forecast Period
Endometrial
cancer is termed as the abnormal growth of endometrium cells in the uterus,
also known as uterine cancer. Endometrial cancer is often diagnosed at an early
stage due to the most common symptom being abnormal vaginal bleeding.
The global endometrial cancer market is estimated to witness remarkable growth
due to the increasing prevalence of endometrial cancer. Other influential
factors such as the growing obesity among women, rise in menopausal hormone
therapy, change in an inactive lifestyle, socioeconomic factors, increasing
consumption of an unhealthy diet, increasing prevalence of Polycystic Ovarian
Syndrome (PCOS), and growing occurrence of breast or ovarian tumor are
contributing towards the market growth. Additionally, diabetes is another
risk factor that leads to endometrial cancer. However, factors such as high
expenditure of diagnostic measures, expensive treatments, and side effects
related to hysterectomy measures are estimated to hamper the market growth
during the forecast period.
Get Sample Report: https://www.marketresearchfuture.com/reports/endometrial-cancer-market-6226
Segmental Analysis
The
global endometrial cancer
market is segmented based on diagnosis, treatment, end-user, and region.
Based on the diagnosis, the endometrial cancer market is segmented into
endometrial biopsy, ultrasound, dilation and curettage (D&C), pelvic
examination, transvaginal and laparoscopy.
Based on treatment, the market has been segmented into radiation, chemotherapy,
hysterectomy techniques, hormone therapy, and palliative care. The radiation
category is segmented into external radiation and internal radiation
(brachytherapy). The chemotherapy segment is segmented into paclitaxel,
doxorubicin, carboplatin, and cisplatin. The hysterectomy techniques segment is
sub-segmented into total vaginal hysterectomy, total laparoscopic hysterectomy,
open abdominal hysterectomy, and robotic hysterectomy. Hormonal therapy is
sub-segmented into luteinizing hormone-releasing hormone agonists, tamoxifen,
progestins, and aromatase inhibitors.
Based on end-user, the global endometrial cancer market is segmented into
hospitals and clinics, diagnostic centers, gynecology centers, ambulatory
surgical centers, feminist health centers, and others.
Based on the region, the global endometrial cancer market is segmented into the
North & Latin America, Europe, Asia-Pacific, and the Middle East and
Africa.
Regional Analysis
North
America dominates the endometrial cancer market share, owing to the increasing
prevalence of breast cancer, rising healthcare expenditure and growing obesity
within the female population and is estimated to retain its foremost market
share over the forecast period due to these influential factors.
Europe
is estimated as the second largest regional market in the global endometrial
cancer market due to the rising prevalence of ovarian cancer in this region and
is estimated to sustain its market growth over the forecast period.
Asia-Pacific
was anticipated to be the fastest growing region for the global endometrial
cancer market. The market is expected to witness growth owing to the rising
prevalence of diabetes in women, changing lifestyle, and growing obesity within
the female population. Additonally, growing number of government initiatives to
improve the healthcare sector in emerging economies such s india, and china,
among others, is also a sginifcant driing factor for the region and is
estimated to contribute to the market growth of the global endometrial cancer
market over the forecast period.
The
Middle East & Africa region is estimated to show gradual growth in the
global endometrial cancer market due to the presence of strict government
policies and regulations, and low-income economies. On the other hand, the
market is predicted to witness growth owing to the rising healthcare
expenditure by the governments, growing private sector in the healthcare
sector, and rise in insurance coverage in the Middle East.
Key players
The
key market players in the global endometrial cancer market are General Electric
Company, Pfizer Inc., Koninklijke Philips N.V., LUPIN, Bayer AG, PHYTON,
Celgene Corporation, Conceptus Inc., Hologic Inc., Johnson & Johnson, Karl
Storz GmbH & Co. Kg, CooperSurgical Inc., LiNA Medical USA, and Boston
Scientific Corporation.
Access Report Details @ https://www.marketresearchfuture.com/reports/endometrial-cancer-market-6226
Related Reports:
Global Neurorehabilitation Devices Market
Research Report—Forecast till 2027
Global Facial Rejuvenation Market
Research Report—Forecast till 2027
Global Whole Exome Sequencing Market
Research Report—Forecast till 2027
Impact of COVID-19 Outbreak on Healthcare
Market
Mechanical Ventilators Market Research
Report—Forecast till 2027
About US:
Market Research
Future (MRFR) enable customers to unravel the complexity of various industries
through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw
Research Reports (3R), Continuous-Feed Research (CFR), and Market Research
& Consulting Services.
Contact us:
Market Research
Future (part of Wantstats Research and Media Private Limited),
99 Hudson
Street,5Th Floor, New York,
New York 10013
Comments
Post a Comment